Literature DB >> 8590632

Iron deprivation results in an increase in p53 expression.

K Fukuchi1, S Tomoyasu, H Watanabe, S Kaetsu, N Tsuruoka, K Gomi.   

Abstract

Deferoxamine (DFO)-induced iron deprivation caused an increase in p53 expression in ML-1 and Raji cells. In ML-1 cells, with express wild type p53, p53 protein levels were transiently increased 6 h after addition of 10(-4)M DFO. In Raji cells, which carry a mutant p53 allele, p53 increased 6 h after addition of 10(-4)M DFO and remained elevated for 24 h. Growth inhibition was observed in both cell types 6 h after addition of 10(-4)M DFO. In both cells, p53 mRNA levels did not increase following incubation with DFO, suggesting that increased p53 expression is the result of a post-transcriptional mechanism. Although increases in wild type p53 protein in ML-1 cells resulted in increases in a p53 target gene, p21cipl/wafl/sdil, this effect was not observed in Raji cells which express a mutant p53 protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590632     DOI: 10.1515/bchm3.1995.376.10.627

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  12 in total

1.  Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro.

Authors:  J Kovár; T Valenta; H Stýbrová
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Jul-Aug       Impact factor: 2.416

2.  Hypoxia links ATR and p53 through replication arrest.

Authors:  Ester M Hammond; Nicholas C Denko; Mary Jo Dorie; Robert T Abraham; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells.

Authors:  J Truksa; J Kovár; T Valenta; M Ehrlichová; J Polák; P W Naumann
Journal:  Cell Prolif       Date:  2003-08       Impact factor: 6.831

4.  Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.

Authors:  Yanru Xue; Gejing Zhang; Shoujie Zhou; Shenghang Wang; Huanhuan Lv; Liangfu Zhou; Peng Shang
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

Review 5.  Iron deprivation in cancer--potential therapeutic implications.

Authors:  Jessica L Heath; Joshua M Weiss; Catherine P Lavau; Daniel S Wechsler
Journal:  Nutrients       Date:  2013-07-24       Impact factor: 5.717

Review 6.  Targeting cancer by binding iron: Dissecting cellular signaling pathways.

Authors:  Goldie Y L Lui; Zaklina Kovacevic; Vera Richardson; Angelica M Merlot; Danuta S Kalinowski; Des R Richardson
Journal:  Oncotarget       Date:  2015-08-07

7.  Prognostic associations of plasma hepcidin in women with early breast cancer.

Authors:  Katarzyna J Jerzak; Ana E Lohmann; Marguerite Ennis; Elizabeta Nemeth; Tomas Ganz; Pamela J Goodwin
Journal:  Breast Cancer Res Treat       Date:  2020-09-22       Impact factor: 4.872

8.  BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.

Authors:  Somayeh Kalanaky; Maryam Hafizi; Saideh Fakharzadeh; Mohammad Vasei; Ladan Langroudi; Ehsan Janzamin; Seyed Mahmoud Hashemi; Maryam Khayamzadeh; Masoud Soleimani; Mohammad Esmaeil Akbari; Mohammad Hassan Nazaran
Journal:  Drug Des Devel Ther       Date:  2015-12-30       Impact factor: 4.162

Review 9.  Intestinal iron homeostasis and colon tumorigenesis.

Authors:  Xiang Xue; Yatrik M Shah
Journal:  Nutrients       Date:  2013-06-28       Impact factor: 5.717

10.  Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.

Authors:  Rayan S Moussa; Zaklina Kovacevic; Des R Richardson
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.